Nano PharmaSolutions is Drug Delivery in United States that focus on developer business. Founded in 2019. They cover business area such as developer, a drug delivery technology, drug solubility, increase surface area, tablet, capsule, drop, inhaler, bioavailability, nano formulation development service, emerge pharma company, client, their drug, clinical stage.
2019
( 5 years old in 2024 )
Developer
-
9853 Pacific Heights Boulevard
Suite O
San Diego, CA 92121
United States
Private
developera drug delivery technologydrug solubilityincrease surface areatabletcapsuledropinhalerbioavailabilitynano formulation development serviceemerge pharma companyclienttheir drugclinical stage
* We use standard office opening hours in near Nano PharmaSolutions's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nano PharmaSolutions is Drug Delivery business from United States that founded in 2019 (5 years old in 2024), Nano PharmaSolutions business is focusing on Developer.
Nano PharmaSolutions headquarter office and corporate office address is located in 9853 Pacific Heights Boulevard Suite O San Diego, CA 92121 United States.
Nano PharmaSolutions was founded in United States.
In 2024, Nano PharmaSolutions is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nano PharmaSolutions, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
